P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical a...

por Specht, HM, Pelzel, J, Hautmann, H, Huber, RM, Schossow, B, Molls, M, Multhoff, G
Publicado 2014